Scinai Immunotherapeutics Ltd (SCNI) support and resistance · P/E 0.2, rev $1.3M
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
This page maps Scinai Immunotherapeutics Ltd (SCNI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
SCNI currently screens at market cap $1.8M and trailing P/E 0.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SCNI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SCNI quote page for the session range and the stock page for the full model.
Not investment advice.